Related Experiment Video
Updated: Nov 2, 2025

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
CircRNAs: Decrypting the novel targets of fibrosis and aging
Yang Yang1, Wangrui Lei1, Shuai Jiang1
1Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Xi'an No.3 Hospital, School of Life Sciences and Medicine, Northwest University, 10 Fengcheng Three Road, Xi'an, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an, China.
Abstract:
Fibrosis is a typical aging-related pathological process involving almost all organs. It is usually initiated by organic injury and leads to the gradual decline of organ function or even loss. Circular RNAs (circRNAs) are being hailed as a newly rediscovered class of covalently closed transcripts without a 5' cap or 3' tail which draw increasing attention. In particular, circRNAs have been identified to be involved in the multifaceted processes of fibrosis in various organs, including the heart, liver, lung, and kidney. As more and more circRNAs are functionally characterized, they have become novel therapies for fibrosis. In this review, we systematically summarized current studies regarding the roles of circRNAs in fibrosis and shed light on the basis of circRNAs as a potential treatment for fibrosis.
Insights
Fibrosis, a common aging process, involves organ damage and function decline. Circular RNAs (circRNAs) show potential as novel therapies for treating fibrosis across multiple organs.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Fibrosis is a pathological aging process affecting nearly all organs, often initiated by injury.
- It leads to progressive organ dysfunction and potential failure.
- Circular RNAs (circRNAs), a unique class of RNA transcripts, are emerging as key players in biological processes.
Purpose of the Study:
- To systematically review the current research on the role of circRNAs in fibrosis.
- To explore the therapeutic potential of circRNAs for treating fibrotic diseases.
Main Methods:
- Literature review of studies investigating circRNAs in fibrotic conditions.
- Analysis of identified circRNAs and their mechanisms in organ fibrosis.
- Summary of current therapeutic strategies involving circRNAs for fibrosis.
Main Results:
- CircRNAs are implicated in the complex mechanisms of fibrosis in organs like the heart, liver, lungs, and kidneys.
- Functional characterization of specific circRNAs reveals their significant roles in fibrotic progression.
- Emerging evidence supports circRNAs as promising therapeutic targets and agents for fibrosis.
Conclusions:
- CircRNAs play a critical role in the pathogenesis of fibrosis across various organs.
- Understanding circRNA functions provides a basis for developing novel anti-fibrotic therapies.
- CircRNAs represent a promising frontier for treating age-related fibrotic diseases.
Related Concept Videos
The Effect of Aging on Tissues
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria
Introduction to Fibroblasts
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

